You are here: Industry Insights > cancer

News List

Developing a new radioactive marker for cancer diagnosis and detection europeanpharmaceuticalreview
April 22, 2019
Scientists are conducting a joint study to develop a radioactive marker, based on nanoparticles, for the detection of cancer…
Saliva diagnostics: Will saliva translate into a real diagnostic tool? europeanpharmaceuticalreview
April 22, 2019
Saliva has been used to measure stress hormones, enzyme levels and cancer mutations…
Blood test can detect early stage pancreatic cancer europeanpharmaceuticalreview
April 22, 2019
A blood test has been developed to detect pancreatic cancer at its earliest stages with an accuracy rate of 96 percent…
Prostate cancer treatment reduced from 37 treatments to 5 europeanpharmaceuticalreview
April 22, 2019
A minimally invasive hydrogel technology was administered, and has previously shown to decrease treatment side effects…
Cardiac monitoring for high-risk breast cancer patients ‘should be prioritised’ europeanpharmaceuticalreview
April 19, 2019
Cardiac monitoring of high-risk breast cancer patients should be prioritised, after research revealed low rates of heart monitoring seen in the patients receiving trastuzumab.
CDC: Recent Decline Seen in High-Grade Cervical Lesions drugs
April 19, 2019
CDC: Recent Decline Seen in High-Grade Cervical Lesions
Some Patients With Imminently Fatal Cancer Undergo Treatment drugs
April 18, 2019
Some patients with imminently fatal de novo metastatic cancer undergo treatment.
New micro-platform improves understanding of cancer cells europeanpharmaceuticalreview
April 18, 2019
A new low-cost, cell culture platform technique may provide insight for more effective cancer treatment, according to the researchers who developed it…
Roche's drugs, new and old, team up for major sales—sans price hikes fiercepharma
April 18, 2019
Last July, Roche put a halt on drug price increases in the U.S. But that didn't stop five of its products from topping analysts' sales estimates by double digits to start the year.
Durvalumab improves survival of non-small cell lung cancer patients europeanpharmaceuticalreview
April 18, 2019
Moffitt researchers conducted a Phase III trial which found durvalumab to increase the survival of patients with non-small cell lung cancer…